Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites

被引:0
|
作者
Shen Chen
Yiqiao Jiao
Yiyang Han
Jie Zhang
Yuanyuan Deng
Zilu Yu
Jiao Wang
Shasha He
Wei Cai
Jixiong Xu
机构
[1] First Affiliated Hospital of Nanchang University,Department of Endocrinology and Metabolism
[2] Jiangxi Clinical Research Center for Endocrine and Metabolic Disease,Queen Mary School, Medical College
[3] Jiangxi Branch of National Clinical Research Center for Metabolic Disease,Department of Medical Genetics and Cell Biology
[4] Nanchang University,undefined
[5] Medical College of Nanchang University,undefined
来源
Acta Diabetologica | 2024年 / 61卷
关键词
T2DM; Edible traditional Chinese medicines; Gut microbiotal metabolites; Short-chain fatty acids; Bile acids; Branched-chain amino acids;
D O I
暂无
中图分类号
学科分类号
摘要
Type 2 diabetes mellitus (T2DM) is a metabolic disorder with intricate pathogenic mechanisms. Despite the availability of various oral medications for controlling the condition, reports of poor glycemic control in type 2 diabetes persist, possibly involving unknown pathogenic mechanisms. In recent years, the gut microbiota have emerged as a highly promising target for T2DM treatment, with the metabolites produced by gut microbiota serving as crucial intermediaries connecting gut microbiota and strongly related to T2DM. Increasingly, traditional Chinese medicine is being considered to target the gut microbiota for T2DM treatment, and many of them are edible. In studies conducted on animal models, edible traditional Chinese medicine have been shown to primarily alter three significant gut microbiotal metabolites: short-chain fatty acids, bile acids, and branched-chain amino acids. These metabolites play crucial roles in alleviating T2DM by improving glucose metabolism and reducing inflammation. This review primarily summarizes twelve edible traditional Chinese medicines that improve T2DM by modulating the aforementioned three gut microbiotal metabolites, along with potential underlying molecular mechanisms, and also incorporation of edible traditional Chinese medicines into the diets of T2DM patients and combined use with probiotics for treating T2DM are discussed.
引用
收藏
页码:393 / 411
页数:18
相关论文
共 50 条
  • [41] Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus
    Yang, Yong
    Han, Zihan
    Gao, Zhaoya
    Chen, Jiajia
    Song, Can
    Xu, Jingxuan
    Wang, Hanyang
    Huang, An
    Shi, Jingyi
    Gu, Jin
    Guo, Lishao
    CHINESE MEDICAL JOURNAL, 2023, 136 (23) : 2847 - 2856
  • [42] Gut microbiota and metabolites in patients with COVID-19 are altered by the type of SARS-CoV-2 variant
    Yokoyama, Yoshihiro
    Ichiki, Tomoko
    Yamakawa, Tsukasa
    Tsuji, Yoshihisa
    Kuronuma, Koji
    Takahashi, Satoshi
    Narimatsu, Eichi
    Katanuma, Akio
    Nakase, Hiroshi
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [43] Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
    Gao, Ruolin
    Meng, Xiangjing
    Xue, Yili
    Mao, Min
    Liu, Yaru
    Tian, Xuewen
    Sui, Bo
    Li, Xun
    Zhang, Pengyi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition
    Zou, Junju
    Xiang, Qin
    Tan, Danni
    Shi, Liuyang
    Liu, Xiu
    Wu, Yongjun
    Yu, Rong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 157
  • [45] Alterations of gut microbiome in patients with type 2 diabetes mellitus who had undergone cholecystectomy
    Wei, Bin
    Wang, Yakun
    Xiang, Shoukui
    Jiang, Yan
    Chen, Rong
    Hu, Nan
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (01): : E113 - E121
  • [46] An Almond-Based Low Carbohydrate Diet Improves Depression and Glycometabolism in Patients with Type 2 Diabetes through Modulating Gut Microbiota and GLP-1: A Randomized Controlled Trial
    Ren, Mengxiao
    Zhang, Huaiyu
    Qi, Jindan
    Hu, Anni
    Jiang, Qing
    Hou, Yunying
    Feng, Qianqian
    Ojo, Omorogieva
    Wang, Xiaohua
    NUTRIENTS, 2020, 12 (10) : 1 - 21
  • [47] Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
    Tanase, Daniela Maria
    Gosav, Evelina Maria
    Neculae, Ecaterina
    Costea, Claudia Florida
    Ciocoiu, Manuela
    Hurjui, Loredana Liliana
    Tarniceriu, Claudia Cristina
    Maranduca, Minela Aida
    Lacatusu, Cristina Mihaela
    Floria, Mariana
    Serban, Ionela Lacramioara
    NUTRIENTS, 2020, 12 (12) : 1 - 26
  • [48] The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects
    Zhao, Yi-Kun
    Zhu, Xiang-Dong
    Liu, Rong
    Yang, Xia
    Liang, Yong-Lin
    Wang, Yan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 3557 - 3566
  • [49] White hyacinth bean polysaccharide ameliorates diabetes via microbiota-gut-brain axis in type 2 diabetes mellitus rats
    Chen, Su -Mei
    Zeng, Fan-Sen
    Fu, Wang-Wei
    You, Hui-Ting
    Mu, Xiao-Yu
    Chen, Guang-Feng
    Lv, Hao
    Li, Wen -Juan
    Xie, Ming-Yong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 253
  • [50] Polysaccharide from tuberous roots of Ophiopogon japonicus regulates gut microbiota and its metabolites during alleviation of high-fat diet-induced type-2 diabetes in mice
    Wang, Huai-You
    Guo, Lin-Xiu
    Hu, Wei-Hui
    Peng, Zhi-Tian
    Wang, Cheng
    Chen, Zhi-Cong
    Liu, Etta Y. L.
    Dong, Tina T. X.
    Wang, Tie-Jie
    Tsim, Karl W. K.
    JOURNAL OF FUNCTIONAL FOODS, 2019, 63